1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
654ACD2AAC18EF41A002585C7003E8782
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/54ACD2AAC18EF41A002585C7003E8782?OpenDocument
18
19OpenDocument
203.215.79.204
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Launch Optimization

Document Excerpt: Maximizing the Impact of Medical Affairs in Hematology Product Launches: Role and Activities

DB Image

Excerpt in Cart

ID: MD-727


Features:

16 Info Graphics

13 Data Graphics

260+ Metrics

10 Narratives


Pages/Slides: 4


Published: 2020


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5627 "Maximizing the Impact of Medical Affairs in Hematology Product Launches: Role and Activities”.

Industries Profiled:
Pharmaceutical; Biotech; Chemical; Medical Device; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Celgene; Crescendo Bioscience; Curis; Daiichi Sankyo; Grifols; Orchard Therapeutics; Roche; Sandoz; Sanofi; Servier; Shire; Takeda Pharmaceuticals; Zydus Cadila

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.